Document is current
Any future updates will be listed below
-
Authors
Sorg, Anna-Lisa https://orcid.org/0000-0002-6255-7758
Hufnagel, Markus https://orcid.org/0000-0002-7420-9136
Doenhardt, Maren https://orcid.org/0000-0001-5800-5435
Diffloth, Natalie https://orcid.org/0000-0002-1822-1413
Schroten, Horst https://orcid.org/0000-0001-8556-0995
von Kries, Rüdiger https://orcid.org/0000-0003-3646-0714
Berner, Reinhard https://orcid.org/0000-0002-6216-9173
Armann, Jakob https://orcid.org/0000-0002-5418-6416
-
Funding
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
- License Information
-
More Information
Article History
Received: 22 February 2022
Revised: 26 July 2022
Accepted: 4 August 2022
First Online: 13 August 2022
Declarations
:
: This studies pooled for these analyses were all performed in line with the principles of the Declaration of Helsinki. The DGPI registry was approved by the Ethics Committee of the Technische Universität (TU) Dresden (BO-EK-110032020) and was assigned clinical trial number DRKS00021506. For the SARS-CoV-2, KIDS Study ethics committees of each of the 14 study center independently approved the study protocol. All parents/guardians gave written informed consent and children assented to the participation when appropriate for their age. All other (anonymized) data was publicly available for scientific purposes.
: For SARS-CoV-2 KIDS study, written informed consent was obtained from the gaurdians. For DGPI survey, consent to participate was not required.
: Not applicable.
: The authors declare no competing interests.
